CN Patent

CN108779117B — 一类激酶抑制剂

Assigned to Chongqing Fushang Yuanchuang Pharmaceutical Technology Co ltd · Expires 2021-08-31 · 5y expired

What this patent protects

本发明涉及一类CDK4/6抑制剂、及其药物组合物和使用方法。

USPTO Abstract

本发明涉及一类CDK4/6抑制剂、及其药物组合物和使用方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN108779117B
Jurisdiction
CN
Classification
—
Expires
2021-08-31
Drug substance claim
No
Drug product claim
No
Assignee
Chongqing Fushang Yuanchuang Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.